The molecular basis for neutrophil dysfunction in early-onset periodontitis

Journal of Periodontology

Volumn 67, Issue 3 SUPPL., 1996, Pages 345-354

  De Nardin, Ernesto ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chemotaxis; Infectious diseases prevention and control; Inflammation prevention and control; Neutrophils

Indexed keywords

EID: 0002735776     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.3s.345     Document Type: Article

References (120)

1. Fernandez HN, Henson PM, Otani A, Hugli TE. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 1978;120:109-115.
2. Cochrane CG, Müller-Eberhard HJ. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med 1968;127:371-386.
3. Ward PA. Leukotaxis and leukotactic disorders. Am J Pathol 1974;77:520-538.
4. Schiffmann E, Corcoran BA, Wahl SM. N-Formylmethionyl peptides as chemoattractants for leukocytes. Proc Natl Acad Sci (USA) 1975;72:1059-1062.
5. Baggiolini M, Dewald B, Thelen M. Effects of PAP on neutrophils and mononuclear phagocytes. Prog Biochem Pharmacol 1988;22: 90-105.
6. Aswanikumar S, Corcoran BA, Schiffman E. et al. Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun 1977;74:810-817.
7. Wilhams LT, Snyderman R, Pike MC, Lefkowitz RJ. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci (USA) 1977;74:1204-1208.
8. 125I-chemotactic peptide by human neutrophils. J Biol Chem 1979;254:10700-10706.
9. 3H]formyl-Nor-Leu-Leu-Phe to plasma membrane of rabbit neutrophils. FEBS Lett 1978;91:305-309.
10. Lala A, Amano A, Sojar HT, Radel SJ, De Nardin E. Porphyromonas gingivalis trypsin-like protease: A possible natural ligand for the neutrophil formyl peptide receptor. Biochem Biophys Res Commun 1994;199:1489-1496.
11. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049.
12. Walz A, Dewald B, von Tscharner V, Baggiolini M. Effects of the neutrophil-activating NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 1989;170:1745-1750.
13. Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 1990;171:1797-1802.
14. Leonard EJ, Yoshimura T. Neutrophil attractant/activation protein-I (NAP-1 (interleukin-8)). Am J Respir Cell Mol Biol 1990;2:479-486.
15. Colditz I, Zwahlen RD, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 1989;134:755-760.
16. Colditz I, Zwahlen RD, Baggiolini M. Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J Leukoc Biol 1990,48:129-137.
17. Smith C, Kishimoto T, Abbass O, et al. Chemotactic factors regulate lectin adhesion molecule-1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 1991;87:609-618.
18. Carveth HJ, Bohnsack JF, McIntyre T, Baggiolini M, Prescott SM, Zimmerman GA. Neutrophil activating factor (NAP) induces potymorphonuclear leukocyte adherence to endothelial cells and to sub-endothelial matrix proteins. Biochem Biophys Res Commun 1989;162:387-393.
19. Lo SK, Detmers PA, Levin SM, Wright SD. Transient adhesion of neutrophils to endothelium. J Exp Med 1989;169:1770-1793.
20. Gimbrone MA Jr., Obin MS, Brock AF, et al. Endothelial interleukin-8: 4 novel inhibitors of leukocyte-endothelial interactions. Science 1959;246:1601-1603.
21. Larsen CG, Andersen AO, Oppenheim JJ, Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology 1989;68:31-36.
22. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1989;1:2-13.
23. Takashiba S, Takigawa M, Takahashi K, et al. Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1β or tumor necrosis factor α. Infect Immun 1992;60:5253-5258.
24. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide NAP-I/IL-8. J Exp Med 1991;173:771-774.
25. Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 1987;69:338-340.
26. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991;253:1278-1280.
27. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991;253: 1280-1283.
28. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-16287.
29. Cerretti DP, Kozlosky CJ, Vanden Bos T, Nelson N, Gearing DP, Beckmann MP. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol Immunol 1993;30:359-367.
30. Schraufstatter I, Oades Z, Ma M, Barritt D, Cochrane C. Interaction of IL-8 with the IL8-B receptor. FASEB J 1995;9:A199.
31. Chuntharapai A, Jin Kim K. Regulation of the expression of IL-8 receptor A|B by IL-8: Possible functions of each receptor. J Immunol 1995;155:2587-2594.
32. Ahuja SK, Shetty A, Tiffany HL, Murphy PM. Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B. J Biol Chem 1994;269:26381-26389.
33. Mueller SG, Schraw WP, Richmond A. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells. J Biol Chem 1994;269:1973-1980.
34. Rosen H. Role of CR3 in induced myelomonocytic recruitment: Insights from in vivo monoclonal antibody studies in the mouse. J Leukoc Biol 1990;48:465-469.
35. Paulson J. Selectin/carbohydrate mediated adhesion of leukocytes. In: Harlan J, Liu D, eds. Adhesion: Its Role in Inflammatory Disease. New York: W.H. Freeman & Co.; 1992:19-42.
36. Fernandez HN, Hugli TE. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. I. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem 1978;253:6955-6962.
37. Hugli TE. The structural basis for anaphylatoxin in chemotactic functions of C3a and C5a. Crit Rev Immunol 1981;1:321-366.
38. Fernandez HN, Hugli TE. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide portions of human C5a. J Immunol 1976;117:1688-1694.
39. Vallota EH, Müller-Eberhard HJ. Formation of C3a and C5a anaphylatoxins in whole serum after inhibition of the anaphylatoxin inactivator. J Exp Med 1973;137:1109-1123.
40. Henson PM, McCarthy K, Larsen GL. et al. Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol 1979;97: 93-105.
41. Bokisch VA, Müller-Eberhard HJ. Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase. J Clin Invest 1970;49:2427-2436.
42. Chenoweth DE, Goodman MG. The C5a receptor of neutrophils and macrophages. Agents Actions Suppl 1983;12:252-273.
43. Snyderman R, Phillips JK. Mergenhagen SE. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med 1971;134:1131-1143.
44. Goldstein IM. Complement: Biologically active products. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press; 1988:55-74.
45. Vogt W, Bodammer G, Lufft E, Schmidt G. Formation of anaphylatoxin in human serum. Experientia 1969;25:744-745.
46. Stimler NP, Brocklehurst WE, Hugli TE, Bloor C. Anaphylatoxin-mediated contraction of guinea pig lung strips: A non-histamine tissue response. J Immunol 1981;126:2258-2261.
47. Stimler NP, Bach MK, Bloor CM, Hugli TE. Release of leukotrienes from guinea pig lung stimulated by C5a des Arg anaphylatoxin. J Immunol 1982;128:2247-2252.
48. Yancy KB. Biological properties of human C5a: Selected in vitro and in vivo studies. Clin Exp Immunol 1988;71:207-210.
49. Henson PM. Zanolari B, Schwartzman NA, Hong SR. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalsin B. J Immunol 1978;121:851-855.
50. Chenoweth DE, Hugli TE. Demonstration of specific C5a receptor on intact polymorphonuclear leukocytes. Proc Natl Acad Sci (USA) 1978;75:3943-3947.
51. Huey R, Hugli TE Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN). J Immunol 1985;135:2063-2068.
52. Johnson RJ, Chenoweth DE. Labeling the granulocyte C5a receptor with a unique photoreactive probe. J Biol Chem 1985;260:7161-7164.
53. Rollins TE, Springer MS. Identification of the polymorphonuclear leukocyte C5a receptor. J Biol Chem 1985;260:7157-7160.
54. Van Epps DE, Simpson S, Bender JG, Chenoweth DE. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J Immunol 1990;144:1062-1068.
55. Verghese MW, Smith CD, Snyderman R. Role of guanine nucleotide regulatory protein in polyphosphoinositide degradation and activation of phagocytic leukocytes by chemoattractants. J Cell Biochem 1986a;32:59-69.
56. Verghese MW, Uhing RI, Snyderman R. A pertussis toxin/cholera toxin-sensitive N protein may mediate chemoattractant receptor signal transduction. Biochem Biophys Res Commun 1986b;138:887-889.
57. Wright SD, Levin SM, Jong MT, Chad Z, Kabbash LG. CR3 (CD11bICDIB) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 1989;169:175-183.
58. Rollins TE, Siciliano S, Kobayashi S, et al. Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex. Proc Natl Acad Sci (USA) 1991;88:971-975.
59. Smith R, Sam L, Leach K, Justen J Postreceptor events associated with human neutrophil activation by interleukin-8. J Leukoc Biol 1992,52:17-26.
60. Berridge MJ. Inositol triphosphate and diacylglycerol: Two interacting second messengers. Annu Rev Biochem 1987;56:159-193.
61. Kikuchi A, Kozawa O, Kaibuchi K, Katada T, Ui M, Takai Y. Direct evidence for involvement of a guanine nucleotide-binding protein in chemotactic peptide-stimulated formation of inositol biphosphate and triphosphate in differentiated human leukemia (HL-60) cells. J Biol Chem 1986;261:11558-11562.
62. Goldman DW, Chang FW, Gifford LA, Goetzl EJ, Bourne HR. Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med 1985;162:145-156.
63. Lad PM, Olson CV, Smiley PA. Association of the N-formyl-MetLeu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin. Proc Natl Acad Sci (USA) 1985;82: 869-873.
64. Becker EL, Kermode JC, Naccache PH, et al. The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin. J Cell Biol 1985;100:1640-1646.
65. Thelen M, Peveri P, Kernen P, von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAP, a novel monocyte-derived peptide agonist. FASEB J 1988;2:2702-2706.
66. Simon MI, Strathmann MP, Gautum N. Diversity of G proteins in signal transduction. Science 1992;252:802-808.
67. Bimbaumer L, Abramowitz J, Brown AM. Receptor-effector coupling by G proteins. Biochim Biophys Acta 1990;1031:163-224.
68. Beals CR, Wilson CB, Perlmutter RM. A small multigene family encodes Gi signal-transducing proteins. Proc Natl Acad Sci (USA) 1987;84:7886-7890.
69. Didsbury JR, Ho YS, Snyderman R. Human Gi protein alpha-subunit: Deduction of amino acid structure from a cloned cDNA. FEBS Lett 1987;211:160-164.
70. Polakis PG, Uhing RJ, Snyderman R. The formylpeptide chemoattractant receptor copurifies with a GTP-binding protein containing a distinct 40 kDa pertussis toxin substrate. J Biol Chem 1988;263:4969-4976.
71. Verghese MW, Charles L, Jakoi L, Dillon SB, Snyderman R. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. J Immunol 1987;138: 4374-4380.
72. Siciliano SJ, Rollins TE, Springer MS. Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states. J Biol Chem 1990;265:19568-19574.
73. Amatruda TT III, Gerard NP, Gerard C, Simon MI. Specific interactions of chemoattractant factor receptors with G-proteins. J Biol Chem 1993;268:10139-10144.
74. Boulay F, Tardif M, Brouchon L, Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990;29:11123-11133.
75. Lefkowitz J, Caron MG. Models for the study of receptors coupled to guanine nucleotide regulatory proteins. J Biol Chem 1988;263: 4993-1996.
76. Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Bokoch GM. Domains of the human N-formyl peptide receptor involved in G protein coupling. J Biol Chem 1994;269:326-331.
77. Koo C, Lefkowitz RJ, Snyderman R. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. Biochem Biophys Res Commun 1982;106:442-449.
78. Jesaitis AJ, Naemura JR, Sklar LA, Cochrane CG, Painter RG. Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: Formation of high affinity ligand-receptor complexes in transient association with cell cytoskeleton. J Cell Biol 1984;98:1378-1387.
79. Jesaitis AJ, Tolley JO, Allen RA. Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced Superoxide production in human granulocytes. J Biol Chem 1986;261:13662-13669.
80. Radel S, Genco RJ, De Nardin E. Localization of the ligand binding regions of the human formyl peptide receptor. Biochem Int 1991;25:745-753.
81. Radel SJ, Genco RJ, De Nardin E. Structural and functional characterization of the human formyl peptide receptor ligand-binding region. Infect Immun 1994;62:1726-1732.
82. Lala A, Sharma A, Sojar H, Radel S, Genco RJ, De Nardin E. Recombinant expression and partial characterization of the human formyl peptide receptor. Biochim Biophys Acta 1993;1178:302-306.
83. Quehenberger O, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. J Biol Chem 1993;268: 18167-18175.
84. Gao J, Murphy PM. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J Biol Chem 1993;268:25395-25401.
85. Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD. The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G-protein coupling. Biochem J 1993;294:581-587.
86. Chou K, Carlacci L, Maggiora GM, Parodi LA, Schulz MW. An energy-based approach to packing the 7-helix bundle of bacteriorhodopsin. Protein Sci 1992;1:810-827.
87. Fodor SPA, Ames JB, Gebhard R, et al. Chromophore structure in bacteriorhodopsin's N intermediate: Implications for the protonpumping mechanism. Biochemistry 1988;27:7097-7101.
88. Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Jesaitis AJ, Bokoch GM. Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein. J Leukoc Biol 1993;53:470-474.
89. Cianciola LJ, Genco RJ, Patters MR, McKenna J, van Oss CJ. Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature 1977;265:445-447.
90. Clark RA, Page RC, Wilde G. Defective neutrophil chemotaxis in juvenile periodontitis. Infect Immun 1977;18:694-700.
91. Lavine WS, Maderazo EG, Stolman J, et al. Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodont Res 1979;14:10-19.
92. Genco RJ, Van Dyke TE, Park B. Ciminelli M, Horoszewicz H. Neutrophil chemotaxis impairment in juvenile periodontitis: Evaluation of specificity, adherence, deformability, and serum factors. J Reticuloendothel Soc 1980;28:81-91.
93. Van Dyke TE, Horoszewicz HU, Cianciola U, Genco RJ. Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun 1980;27:124-132.
94. Van Dyke TE, Levine MJ, Tabak LA, Genco RJ. Reduced chemotactic peptide binding in juvenile periodontitis: A model for neutrophil function. Biochem Biophys Res Commun 1981;100: 1278-1284.
95. Lester M, Schneider A, Warbington M, Van Dyke TE. Defective neutrophil chemotaxis to interleukin-8 in localized juvenile periodontitis patients. J Dent Res 1992;71(Spec. Issue):653 (Abstr. 1102).
96. Van Dyke TE, Schweinebraten M, Cianciola LJ, Offenbacher S, Genco RJ. Neutrophil chemotaxis in families with localized juvenile periodontitis. J Periodont Res 1985;20:503-514.
97. Van Dyke TE, Zinney W, Winkel K, Tauriq A, Offenbacher S, Arnold RR. Neutrophil function in localized juvenile periodontitis. Phagocytosis, Superoxide production and specific granule release. J Periodontol 1986;57:703-708.
98. Saxen L, Nevanlinna HR. Autosomal recessive inheritance of juvenile periodontitis: Test of a hypothesis. Clin Genet 1984;25:332-335.
99. Saxen L, Murtomaa H. Age-related expression of juvenile periodontitis. J Clin Periodontol 1985;12:21-26.
100. Long JC, Nance WE, Waring P, Burmeister JA, Ranney RR. Early onset periodontitis: A comparison and evaluation of two proposed modes of inheritance. Genet Epidemiol 1987;4:13-24.
101. Löe H, Brown LJ. Early onset periodontitis in the United States of America, J Periodontol 1991;62:608-616.
102. De Nardin E, De Luca C, Levine MJ, Genco RJ. Antibodies directed to the chemotactic factor receptor detect differences between chemotactically normal and defective neutrophils from LJP patients. J Periodontol 1990;61:609-617.
103. Perez HD, Kelly E, Elfman F, Armitage G, Winkler J. Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis. J Clin Invest 1991;87:971-976.
104. Van Dyke TE, Wilson BC, Offenbacher S, Henson P. Association of an abnormality of neutrophil chemotaxis in human periodontal disease with a cell surface protein. Infect Immun 1987;55:2262-2267.
105. Coles RB, Ranney RR, Freer J, Carchman RA. Thermal regulation of FMLP receptors on human neutrophils. J Leukoc Biol 1989;45: 529-537.
106. Daniel MA, McDonald G, Offenbacher S, Van Dyke TE. Defective chemotaxis and calcium response in localized juvenile periodontitis neutrophils. J Periodontol 1993;64:617-621.
107. Goetzl EJ, Foster DW, Goldman DW. Isolation and partial characterization of membrane protein constituents of human neutrophil receptors for chemotactic formylmethionyl peptides. Biochemistry 1981;20:5717-5722.
108. Huang CJ. Partial purification and characterization of formylpeptide receptor from rabbit peritoneal neutrophils. J Leukoc Biol 1987;1:63-69.
109. De Nardin E, Radel SJ, Genco RJ. Isolation and partial characterization of the formyl peptide receptor components on human neutrophils. Biochem Biophys Res Commun 1991;174:84-89.
110. Boulay F, Tardif M, Brouchon L, Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun 1990;168: 1103-1109.
111. De Nardin E, Radel S, Genco RJ. Identification of a gene encoding for the human formyl peptide receptor. Biochem Int 1992;26:381-387.
112. Simon P, Brocas H, Baran D, van Geffel R, Rodesch F, Vassart G. Carrier prediction of cystic fibrosis in 36 families by means of restriction fragment length polymorphism. Eur J Pediatr 1988;147: 199-201.
113. Savige JA, Patrikios V, Aldred P, Kincaid SP. Use of a DNA probe in the diagnosis of adult polycystic kidney disease. Aust N Z J Med 1988;18:674-678.
114. Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res 1989;49:145-148.
115. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphism of human DNA by gel electrophoresis as single strand conformational polymorphism. Proc Natl Acad Sci (USA) 1989;86:2766-2770.
116. Ainsworth PJ, Surh LC, Coulter-Mackie MB. Diagnostic single strand conformational polymorphism (SSCP): A simplified non-radioisotopic method as applied to Tay-Sachs B1 variant. Nucleic Acids Res 1991;9:405-406.
117. Dockhorn-Dworniczak B, Dworniczak B, Brömmelkamp L, Bülles J, Horst J, Böcker WW. Non-isotopic detection of single strand conformational polymorphism (PCR-SSCP): A rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res 1991;19:2500.
118. Prossnitz ER, Schreiber RE, Bokoch GM, Ye RD. Binding of low affinity N-formyl peptide receptor to G protein. J Biol Chem 1995;270:1-9.
119. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349:614-617.
120. Thomas KM, Taylor L, Navarro J. The Interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R. J Biol Chem 1991;266:14839-14841.